BRUSSELS, June 19 (Reuters) - EU antitrust regulators are set to fine French drugmaker Servier, Israel's Teva and several of their peers next month for blocking cheaper generic medicine, two people with knowledge of the matter said on Thursday.
The sanctions will be the third action by the European Commission against so-called pay-for-delay deals in the pharmaceutical industry, where brand-name companies pay generics firms to refrain from putting rival medicines on the market.
Help employers find you! Check out all the jobs and post your resume.
